Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 346 of 5804
-
New drug combo shows promise for esophageal cancer before surgery
Disease control Not yet recruitingThe goal of this Phase 2 clinical trial is to learn if the combination of Camrelizumab and Palbociclib is a safe and effective treatment when given before surgery (neoadjuvant therapy) for patients with esophageal squamous cell carcinoma (ESCC) that can be surgically removed. Cam…
Phase: PHASE2 • Sponsor: West China Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Can dry plasma save lives in the field? new trial aims to find out
Disease control Not yet recruitingThe overall goal of this clinical trial is to study how prehospital transfused dry plasma affect outcomes in terms of mortality as well as complications and coagulation status of patients in or about to develop bleeding shock. Researchers will compare dry plasma to standard care…
Phase: PHASE4 • Sponsor: Vastra Gotaland Region • Aim: Disease control
Last updated Jun 26, 2026 18:17 UTC
-
New heart artery treatment could save millions: hybrid strategy tested against standard stenting
Disease control Not yet recruitingThe number of deaths from heart disease is rising globally, particularly in developing countries. This condition involves the narrowing of arteries that supply blood to the heart. The most critical narrowing occurs in the left main coronary artery (LMCA), which supplies blood to …
Phase: NA • Sponsor: Hospital Sultanah Bahiyah • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Can a common diabetes drug protect the heart? new trial aims to find out
Disease control Not yet recruitingEvaluating the safety and efficacy of glimepiride in patients with type 2 diabetes and chronic heart failure with reduced ejection fraction--a multicenter randomized controlled study.
Phase: PHASE3 • Sponsor: Tongji Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Could blood filtering ease long COVID? new trial aims to find out
Disease control Recruiting nowSome people continue to have serious symptoms long after COVID-19, such as extreme fatigue and feeling worse after activity. In some patients, this may happen because the immune system is attacking the body by mistake. This study will test a treatment called immunoadsorption, wh…
Phase: PHASE2 • Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
New PTSD therapy offers hope for War-Torn ukraine
Symptom relief Recruiting nowThe Lux4UA project aims to support mental health treatment in Ukraine, especially for those who have experienced traumatic events due to the ongoing conflict and forced displacement. As rates of Post-Traumatic Stress Disorder (PTSD) rise among civilians, military personnel, and r…
Phase: NA • Sponsor: University of Luxembourg • Aim: Symptom relief
Last updated Jun 27, 2026 08:11 UTC
-
Could less surgery be just as good for breast cancer patients?
Disease control Not yet recruitingSENOMAC-ULTRA enrols patients who are planned for upfront surgery for a breast cancer that has spread to lymph nodes in the armpit, and that have been detected already prior to surgery by imaging, e.g. ultrasonography. In this situation, a full axillary lymph node dissection, rem…
Phase: NA • Sponsor: Karolinska Institutet • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
New study aims to outsmart relapse in aggressive blood cancers after transplant
Disease control Not yet recruitingDonor lymphocyte infusion (DLI) based on minimal residual disease (MRD) has been widely adopted worldwide to enhance the graft-versus-leukemia effect following allogeneic hematopoietic stem cell transplantation (allo-HSCT). However, there is a lack of studies comparing the effica…
Phase: NA • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Glowing needle could spot hidden breast tumors in real time
Diagnosis Recruiting nowThis prospective, multicenter cohort study investigates the differences in the reliability of rapid pathology compared to postoperative pathology when utilizing a novel fluorescent localization needle equipped with a controllable shedding quantum dot chiral nanofluorescent coatin…
Phase: NA • Sponsor: The Fourth Affiliated Hospital of China Medical University • Aim: Diagnosis
Last updated Jun 27, 2026 13:05 UTC
-
Could a cheap arthritis drug prevent heart attacks?
Disease control Recruiting nowThis study is a prospective, multicenter, randomized controlled clinical trial designed to evaluate whether an anti-inflammatory medication can help improve heart health in patients with stable coronary artery disease. 1. Research Question \& Hypothesis We aim to determine wheth…
Phase: PHASE4 • Sponsor: Nanjing First Hospital, Nanjing Medical University • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New drug combo aims to speed blood recovery in cancer transplants
Disease control Recruiting nowAutologous hematopoietic stem cell transplantation(auto-HSCT) plays an important role in treating hematologic malignancies. Mobilization and collection of peripheral blood stem/progenitor cells is the key to successful autologous hematopoietic stem cell transplantation. Currently…
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New drug targets Hard-to-Treat heart condition
Disease control Not yet recruitingThis study is a prospective interventional cohort study aimed at evaluating the therapeutic efficacy and clinical utility of Mavacamten-a targeted myosin inhibitor specifically developed for obstructive hypertrophic cardiomyopathy (HCM)-in patients with HCM characterized by mid-t…
Phase: PHASE4 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New drug duo takes on stubborn Epstein-Barr virus
Disease control Recruiting nowThis study is a multicenter, prospective, single-arm clinical investigation, with patients with CAEBVD as the main research subjects, to evaluate the effectiveness of the combined treatment regimen of golidocitinib and selinexor.
Phase: PHASE2, PHASE3 • Sponsor: Beijing Friendship Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New program aims to close the 'Deadly Gap' for veterans leaving service
Disease control Recruiting nowBackground Young Veterans in the U.S. face a heightened risk of suicide, particularly during the first year after leaving military service-a period often referred to as the "deadly gap." Suicide rates among Veterans aged 18 to 34 have nearly doubled since 2001, and research shows…
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Cord blood transplant offers new hope for rare EBV diseases
Disease control Recruiting nowThis clinical trial is designed as a single-arm, two-center, open-label, prospective study. All participants are enrolled in the standard-dose unrelated umbilical cord blood transplantation group to evaluate the efficacy and safety of unrelated umbilical cord blood transplantatio…
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Can stem cell exosomes heal the womb and boost fertility?
Disease control OngoingIntrauterine adhesions (IUA) is a group of diseases caused by endometrial injury leading to occlusion of the uterine cavity and serious abnormality of the uterine cavity morphology, which causes primary or secondary infertility by affecting embryo implantation. At present, the po…
Phase: NA • Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New cocktail aims to shrink head and neck tumors before surgery
Disease control Recruiting nowThe goal of this clinical trial is to evaluate the efficacy and safety of a novel combination therapy for locally advanced head and neck squamous cell carcinoma (HNSCC). The therapy combines the JAK1 inhibitor Sulfamethoxazole, the anti-PD-L1 antibody Adebrelimab, and chemotherap…
Phase: PHASE2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New combo therapy aims to shrink rectal tumors faster
Disease control Recruiting nowThis study adopts a prospective randomized controlled design to evaluate the efficacy and safety of short-course radiotherapy followed by sequential PD-1 inhibitor and FOLFOX chemotherapy versus conventional regimens in high-risk locally advanced pMMR/MSS lower rectal adenocarcin…
Phase: PHASE2 • Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
AI reads skin biopsies to spot hidden lymphomas
Diagnosis OngoingCutaneous lymphoproliferative diseases (CLPDs) are a group of skin disorders that range from benign conditions, such as pseudolymphomas, to malignant forms like cutaneous T-cell and B-cell lymphomas. Mycosis fungoides is the most common malignant type, but diagnosis is often diff…
Sponsor: Cairo University • Aim: Diagnosis
Last updated Jul 17, 2026 00:00 UTC
-
Video games may unlock a new path to treat dyslexia
Disease control Recruiting nowDevelopmental dyslexia is a common and serious specific learning disability affecting up to one in eight children in Hong Kong, with profound consequences for academic success and personal well-being. For children learning to read the visually complex Chinese script, the challeng…
Phase: NA • Sponsor: The Hong Kong Polytechnic University • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC